# The Effect of Antihypertensive Medication Timing on Morbidity and Mortality

Study · id `cardio:ct-nct02990663` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02990663](<https://clinicaltrials.gov/study/NCT02990663>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02990663

Browse, organ or system: Heart; Blood vessels; Brain  
Browse, condition area: High blood pressure; Coronary and vascular disease; Stroke; Heart failure; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3357 participants.

## Technical summary

Registry record NCT02990663. Randomized; single masking; primary purpose treatment. Start 2017-03-31 (actual); primary completion 2023-12-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3357 participants (enrolled count; ClinicalTrials.gov record NCT02990663, source copy `cardio:ctgov-nct02990663-2024-08-27`, retrieved 2026-10-26)
- Started: 2017-03-31 (actual) (ClinicalTrials.gov record NCT02990663, source copy `cardio:ctgov-nct02990663-2024-08-27`, retrieved 2026-10-26)
- Primary completion: 2023-12-22 (actual) (ClinicalTrials.gov record NCT02990663, source copy `cardio:ctgov-nct02990663-2024-08-27`, retrieved 2026-10-26)
- Completion: 2023-12-22 (actual) (ClinicalTrials.gov record NCT02990663, source copy `cardio:ctgov-nct02990663-2024-08-27`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT02990663, source copy `cardio:ctgov-nct02990663-2024-08-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02990663-2024-08-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Antihypertensive Medication Timing on Morbidity and Mortality
- Condition: Hypertension
- Intervention (Other): Use of blood pressure lowering medication at bedtime
- Intervention (Other): Use of blood pressure lowering medication in the morning
- Lead sponsor: University of Alberta
- Lead sponsor class: OTHER
- Collaborator: Alberta Innovates Health Solutions
- Collaborator class: OTHER
- Collaborator: Alberta Health services
- Collaborator class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Alberta (`cardio:org-university-of-alberta`)
- Registry lists this organization as a collaborator: Alberta Innovates Health Solutions (`cardio:org-alberta-innovates-health-solutions`)
- Registry lists this organization as a collaborator: Alberta Health services (`cardio:org-alberta-health-services`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial (`cardio:pubmed-40354045`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 46419de5ddd0f29b5b390ae0da82c264e96631e90d3f49818484d63a94ce03b8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
